Dr. Cristin Davidson and Dr. Steven Walkley
Dr. Cristin Davidson has been researching treatments for NPC for a decade, including cyclodextrin, a treatment she discovered in early 2006. Dr. Steven Walkley has spent more than 30 years researching lysosomal diseases like NPC.
Cristin Davidson is a post-doctoral fellow at the Albert Einstein College of Medicine. Steven Walkley is the director of the Rose F. Kennedy Intellectual and Developmental Disability Research Center and of the Dominick P. Purpura Department of Neuroscience at Albert Einstein College of Medicine in New York City.
Drs. Davidson and Walkley coordinate with SOAR (Support Of Accelerated Research), a collaboration of multiple labs dedicated to developing NPC treatments.
One of Drs. Davidson and Walkley's main focuses is developing a cyclodextrin treatment that doesn't cause hearing loss.